Top Qs
Timeline
Chat
Perspective
Dusigitumab
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGF2.[1][2] It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix.[3] Its development has been discontinued.[2]
 | This article needs additional citations for verification. (February 2023) |
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads